Leitlinie
Assessing potential herb-drug interactions: A clinical decision-making guideline to mitigate patient risk
Integrative Cancer Science and Therapeutics · 2014
DOI: 10.15761/icst.1000107 ↗Kurz gefasst
Leitlinie in der Zeitschrift Integrative Cancer Science and Therapeutics, 2014. Verfasst von Shauna Birdsall. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Birdsall, S. (2014). Assessing potential herb-drug interactions: A clinical decision-making guideline to mitigate patient risk. Integrative Cancer Science and Therapeutics. https://doi.org/10.15761/icst.1000107
Vancouver
Birdsall S. Assessing potential herb-drug interactions: A clinical decision-making guideline to mitigate patient risk. Integrative Cancer Science and Therapeutics. 2014. doi:10.15761/icst.1000107
BibTeX
@article{Birdsall2014,
author = {Birdsall, Shauna},
title = {Assessing potential herb-drug interactions: A clinical decision-making guideline to mitigate patient risk},
journal = {Integrative Cancer Science and Therapeutics},
year = {2014},
doi = {10.15761/icst.1000107}
}
EUVIMED